Skip navigation
THE BLACK HOLE

A resourcing model for translational research

How the Techna Institute’s team of professionals helps start-ups in Toronto by providing experts for secondment, in a cost-recovery model.

By JONATHAN THON | JAN 31 2018

Last week I spoke out about changing institutional thinking on translational research programs. Specifically, I recommended the reduction of time from grant submission to award, allowances for greater flexibility in project spending, and support for private “start up” lab space outside of the university through direct funding to the company/PI. 

Among the most compelling feedback we received was the suggestion by Drs. John Robertson and Luke Brzozowski at Techna, an institute of University Health Network in Toronto, of creating a pool of talent to help start-ups and academic labs to fill gaps in translational funding. I’ll let them explain…

There’s an important Catch-22 at the heart of Dr. Jonathan Thon’s first suggestion to improve translational research funding in his latest column for The Black Hole: start-ups may lack the resources to keep a project team employed while waiting for a grant result, but often need to show that the team is in place at the time of application to get the grant. And this applies to translational research teams still within a research institute as well, with granting agencies increasingly asking for CVs from key personnel such as project managers – not just the co-applicants.

A related challenge is that start-ups tend to hire (or create) generalists, out of necessity with head counts smaller than the hats to be worn, or because the work for a given specialty would not require a full-time position.

At the Techna Institute in Toronto (part of University Health Network), we’ve helped internal projects and start-ups get around this challenge by having a team of professionals available for secondment in a cost-recovery model.

For example, one of our technology development team members may have a main project within the institution with a long-term commitment covering the majority of their time, but they will also spend a portion of their time supporting shorter-term projects within the institute or with a start-up company. In another case, one of our engineering project managers may be working on a grant-supported translational research project within the research institute with a commitment of half their time, and spend a smaller portion with a start-up company, helping them develop documentation and procedures for ISO 13485 certification.

Depending on the need and availability, it may involve a temporary full-time secondment to a company. And the model covers a spectrum of flexible work arrangements. For example,  our creative designers typically work on multiple small-scale projects with short timelines and commitments. Perhaps the most diverse and mutually beneficial relationships that Techna has had over the years is with Acumyn, a local start-up company. Over the years Techna has provided services like project management, software development, medical physics advice and guidance, regulatory and quality affairs, marketing, technical writing, and accounting. As Acumyn has grown, most of the roles have been assumed by the company, leaving Techna personnel with valuable experience and free to pursue other projects within the community.

Changing the way funding agencies work is worth suggesting, but given the world as it is, we feel that the Techna model is another solution to the problem that institutions and their start-ups should investigate. Techna was founded with philanthropic support just over six years ago, and our team of over 40 engineers, technical project managers, designers, developers, quality and regulatory specialists, financial professionals, (and more!) grew in response to demand within the research and start-up community. The philanthropic support through The Princess Margaret Cancer Foundation was vital for starting the model, after which the team’s service-oriented business model permitted growth at full cost-recovery. The demand for services over the years has helped Techna grow and reach a point of self-sustainability – though self-sustaining/cost-recovery does not necessarily provide capital for further growth, which will continue to depend upon philanthropic support or more profitable contracts with external partners.

While we’re more than happy to work with start-ups and academic innovators across Canada or around the world, we feel that this resourcing model may be one that other institutions may wish to investigate to solve challenges for start-ups and other translational ventures.

Dr. Robertson is Techna’s research strategy development specialist, University Health Network in Toronto. Dr. Brzozowski is senior director, Techna Innovation, University Health Network.

ABOUT JONATHAN THON
Jonathan Thon
Dr. Thon is the CEO and chief scientific officer of Platelet BioGenesis, and a faculty member in the hematology division at Brigham and Women’s Hospital, and Harvard Medical School in Boston.
COMMENTS
Post a comment
University Affairs moderates all comments according to the following guidelines. If approved, comments generally appear within one business day. We may republish particularly insightful remarks in our print edition or elsewhere.

Your email address will not be published. Required fields are marked *

  1. Rosemary Martino / January 31, 2018 at 2:36 pm

    I can speak first hand that the Techna model is excellent. Their support was critical in our lab being successful to obtain funding for a large multi-site international RCT.

  2. Ferhan Bulca / January 31, 2018 at 8:47 pm

    Techna successfully fills an important gap in the start-up eco-system. Techna provided Acumyn highly skilled and professional staff, who understand the challenges and rewards associated with working entrepreneurs. This model allowed Acumyn’s limited resources to focus on developing its core value proposition and have access to the skills that are needed part-time.

  3. Juergen Oellig / February 1, 2018 at 5:55 am

    We started our cooperation with Techna in 2013. Everyone at Techna has a deep understanding of the challenges associated with a start-up in the medical device industry. The support that we received during this time has been excellent. Direct interaction, immediate responses, channeling information to highly skilled experts within the large UHN organisation are only a few advantages that we enjoyed while working with Techna. Highly recommended.

« »
--ph--